Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. 89Bio Inc.

    World Rank (Jan-05-2024)
    8,293
    Market Cap (Jan-05-2024)
    1.062 Billion USD
    World Rank (Jul-30-2023)
    7,991
    Market Cap (Jul-30-2023)
    1.162 Billion USD
    World Rank (Dec-25-2022)
    12,003
    Market Cap (Dec-25-2022)
    0.532 Billion USD
    World Rank (Jan-07-2022)
    17,461
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -102 Million USD
    Annual Net Income in USD
    -102 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    89bio is a Clinical Stage Biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio metabolic diseases. The headquarters is in USA.

  2. MannKind Corporation

    World Rank (Jan-05-2024)
    8,442
    Market Cap (Jan-05-2024)
    1.030 Billion USD
    World Rank (Jul-30-2023)
    7,743
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,058
    Market Cap (Dec-25-2022)
    1.340 Billion USD
    World Rank (Jan-07-2022)
    9,303
    Market Cap (Jan-07-2022)
    1.02 Billion USD
    Annual Revenue in USD
    100 Million USD
    Annual Operating Income in USD
    -69 Million USD
    Annual Net Income in USD
    -87 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Mankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.
  3. Cassava Sciences

    World Rank (Jan-05-2024)
    8,571
    Market Cap (Jan-05-2024)
    1.001 Billion USD
    World Rank (Jul-30-2023)
    9,406
    Market Cap (Jul-30-2023)
    0.876 Billion USD
    World Rank (Dec-25-2022)
    7,118
    Market Cap (Dec-25-2022)
    1.322 Billion USD
    World Rank (Jan-07-2022)
    6,450
    Market Cap (Jan-07-2022)
    1.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -76 Million USD
    Annual Net Income in USD
    -76 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Cassava Sciences is a clinical stage biopharmaceutical company focused on neuroscience. The headquarters is in USA.
  4. Tango Therapeutics Inc.

    World Rank (Jan-05-2024)
    8,692
    Market Cap (Jan-05-2024)
    0.981 Billion USD
    World Rank (Jul-30-2023)
    16,442
    Market Cap (Jul-30-2023)
    0.270 Billion USD
    World Rank (Dec-25-2022)
    10,431
    Market Cap (Dec-25-2022)
    0.690 Billion USD
    World Rank (Jan-07-2022)
    10,643
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Annual Revenue in USD
    37 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Tango Therapeutics is a Biotechnology company with the genetic alterations that fuel cancer by inactivating tumour suppressor genes and helping cancer cells evade killing by the immune system. The headquarters is in USA.

  5. Cabaletta Bio

    World Rank (Jan-05-2024)
    8,870
    Market Cap (Jan-05-2024)
    0.949 Billion USD
    World Rank (Jul-30-2023)
    12,668
    Market Cap (Jul-30-2023)
    0.507 Billion USD
    World Rank (Dec-25-2022)
    16,900
    Market Cap (Dec-25-2022)
    0.247 Billion USD
    World Rank (Jan-07-2022)
    22,679
    Market Cap (Jan-07-2022)
    0.10 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -54 Million USD
    Annual Net Income in USD
    -53 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  6. CureVac

    World Rank (Jan-05-2024)
    8,888
    Market Cap (Jan-05-2024)
    0.945 Billion USD
    World Rank (Jul-30-2023)
    5,858
    Market Cap (Jul-30-2023)
    1.945 Billion USD
    World Rank (Dec-25-2022)
    7,544
    Market Cap (Dec-25-2022)
    1.197 Billion USD
    World Rank (Jan-07-2022)
    2,943
    Market Cap (Jan-07-2022)
    5.74 Billion USD
    Annual Revenue in USD
    74 Million USD
    Annual Operating Income in USD
    -276 Million USD
    Annual Net Income in USD
    -275 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    CureVac is the leading global Clinical Stage Biopharmaceutical company focused on the development of a completely new class of drugs based on the messenger RNA (mRNA). The headquarters is in Germany.

  7. POINT Biopharma Global Inc.

    World Rank (Jan-05-2024)
    8,923
    World Rank (Jul-30-2023)
    8,923
    Market Cap (Jul-30-2023)
    0.962 Billion USD
    World Rank (Dec-25-2022)
    10,135
    Market Cap (Dec-25-2022)
    0.727 Billion USD
    World Rank (Jan-07-2022)
    13,170
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Annual Revenue in USD
    226 Million USD
    Annual Operating Income in USD
    125 Million USD
    Annual Net Income in USD
    98 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    POINT Biopharma Global Inc. is a Clinical Stage Global Pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. The headquarters is in USA.
  8. 4D Molecular Therapeutics Inc.

    World Rank (Jan-05-2024)
    9,373
    Market Cap (Jan-05-2024)
    0.862 Billion USD
    World Rank (Jul-30-2023)
    10,151
    Market Cap (Jul-30-2023)
    0.768 Billion USD
    World Rank (Dec-25-2022)
    10,358
    Market Cap (Dec-25-2022)
    0.699 Billion USD
    World Rank (Jan-07-2022)
    12,298
    Market Cap (Jan-07-2022)
    0.60 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -110 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    4D Molecular Therapeutics is an Innovative Gene Therapy company designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company annual revenue is 6.99 million USD and 78 employees as on 2019. The headquarters is in USA.

Share

Ads